首页> 外文期刊>Cell >Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques
【24h】

Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques

机译:疫苗引发抗体的被动转移保护恒河猴猕猴的SIV

获取原文
获取原文并翻译 | 示例
           

摘要

Several HIV-1 and SIV vaccine candidates have shown partial protection against viral challenges in rhesus macaques. However, the protective efficacy of vaccine-elicited polyclonal antibodies has not previously been demonstrated in adoptive transfer studies in nonhuman primates. In this study, we show that passive transfer of purified antibodies from vaccinated macaques can protect naive animals against SIVmac251 challenges. We vaccinated 30 rhesus macaques with Ad26-SIV Env/Gag/Pol and SIV Env gp140 protein vaccines and assessed the induction of antibody responses and a putative protective signature. This signature included multiple antibody functions and correlated with upregulation of interferon pathways in vaccinated animals. Adoptive transfer of purified immunoglobulin G (IgG) from the vaccinated animals with the most robust protective signatures provided partial protection against SIVmac251 challenges in naive recipient rhesus macaques. These data demonstrate the protective efficacy of purified vaccine-elicited antiviral antibodies in this model, even in the absence of virus neutralization.
机译:一些HIV-1和SIV候选疫苗在恒河猴身上显示出对病毒挑战的部分保护。然而,疫苗诱导的多克隆抗体的保护效力此前在非人灵长类过继转移研究中尚未得到证实。在这项研究中,我们表明被动转移来自接种过疫苗的猕猴的纯化抗体可以保护未接种的动物免受SIVmac251的挑战。我们用Ad26 SIV-Env/Gag/Pol和SIV-Env-gp140蛋白疫苗接种了30只恒河猴,并评估了抗体反应的诱导和假定的保护性标志。该特征包括多种抗体功能,并与免疫动物中干扰素途径的上调相关。过继转移来自具有最强大保护特征的接种动物的纯化免疫球蛋白G(IgG),在未接种的受体恒河猴中对SIVmac251挑战提供了部分保护。这些数据表明,在这种模型中,即使在没有病毒中和的情况下,纯化疫苗也能产生抗病毒抗体。

著录项

  • 来源
    《Cell》 |2020年第1期|共26页
  • 作者单位

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Case Western Reserve Univ Cleveland OH 44106 USA;

    Case Western Reserve Univ Cleveland OH 44106 USA;

    Scripps Res Inst La Jolla CA 92037 USA;

    Scripps Res Inst La Jolla CA 92037 USA;

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Ctr Virol &

    Vaccine Res Boston MA 02215 USA;

    Univ Massachusetts Med Sch Worcester MA 01605 USA;

    Bioqual Rockville MD 20852 USA;

    MIT Cambridge MA 02139 USA;

    Scripps Res Inst La Jolla CA 92037 USA;

    Case Western Reserve Univ Cleveland OH 44106 USA;

    MIT Ragon Inst MGH Cambridge MA 02139 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号